Anne Doering

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

HBM Partners AG (HBM-P) was established in 2001 as an independent provider of investment advisory services with headquarters in Zug, Switzerland. HBM-P's field of expertise comprises global human medicine, biotechnology, medical technology and related sectors. The firm primarily advises HBM BioVentures AG and HBM BioCapital via their Cayman Islands-based, wholly-owned subsidiary, HBM Partners (Cayman) Ltd., which acts as the investment manager for the HBM funds. They rely on the services of an external consultant to analyze investment opportunities in the US.

Cylene Pharmaceuticals, Inc. discovers, develops and commercializes small molecule drugs. It develops molecule drugs to treat life-threatening diseases, with a particular emphasis in oncology. The firm drug discovery platform, STAND has delivered a diverse portfolio of drug candidates that target the multiple pathways critical for the support, maintenance of cancer cells and that address unmet medical needs with substantial markets. The company was founded in 1997 by Thomas James Farrell and Daniel Douglas Von Hoff and is headquartered in San Diego, CA.

Franklin Templeton Investment Management Ltd. (FTIML) is the Great Britain-based global investment management subsidiary of Franklin Templeton Global Investors Ltd., itself a subsidiary of Franklin Resources, Inc. (NYSE: BEN) in the US. Founded in 1985, FTIML is headquartered in London and provides investment advisory and portfolio management services to clients in jurisdictions worldwide, which include registered open-end and closed-end funds and unregistered funds, as well as Separate Accounts for institutional and high net-worth clients.

Memorial Sloan-Kettering Cancer Center operates as a private cancer center. It offers cancer care services to adult; and child and teen patients. Its services include risk assessment and screening; diagnosis and treatment; clinical trials; patient and caregiver education; and pediatric clinical trials. The company was founded by John J. Astor and Charlotte Astor in 1884 and is headquartered in New York, NY.

TeGenero AG discovers and develops novel therapeutics. It is a biopharmaceutical company providing services in the identification and development of effective and applicable therapeutics for the treatment of severe immunological disorders. It's first development candidate TGN1412, a SuperMAB with specificity for the T cell surface receptor CD28 is in non-clinical development. Clinical applications of SuperMAB and its derived compounds are expected to solve unmet medical needs in the fields of cancer-related immunodeficiencies such as B-cell chronic lymphocytic leukaemia and autoimmune/inflammatory diseases like rheumatoid arthritis. The company was founded in 2000 and is headquartered in Wurzburg, Germany.

Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland.

Landesbank Baden-Württemberg (Broker) (LBBW-Broker) is the brokerage division of Landesbank Baden-Württemberg in Germany. Headquartered in Stuttgart, the firm was founded in 1999 and provides capital market services to medium-sized companies, listed groups, institutional customers, savings banks and retail customers.

Part of The Hearst Family Trust, Fitch Deutschland GmbH is a German company that provides investment research. The private company is based in Frankfurt, Germany. Clemens Frech has been the CEO of the company since 2015.

credentis ag designs, develops, manufactures, and markets dental devices. The firm offers CURODONT. The company was founded by Dominik A. Lysek in January 2010 and is headquartered in Windisch, Switzerland.

StartAngels Network operates as a platform for business angel investors. Its angle investors invest directly in the start-up companies, coach them, and provide useful contacts. The company was founded by Peter H. Müller in 2000 and is headquartered in Zurich, Switzerland.

YouRehab AG creates interactive therapy systems for neurological motor disorders. It offers YouGrabber, an all-in-one upper limb rehabilitation product for arms and fingers, which trains patients at peak intensity using rehabilitation gaming to enahcne clinical outcomes; YouKicker, a lower limb rehabilitation product for legs and feet. The company was founded by Oliver Ullmann, Kynan Eng, Edith Chevrier, Lisa Holper, Daniel Kiper, Pawal Pyk and Ewa Siekierka in April 2010 and is headquartered in Schlieren, Switzerland.

Advanced Osteotomy Tools-AOT AG develops, manufactures, and markets medical devices and tools for bone-cutting. Its device combines three-dimensional (3D) pre-operative planning and a navigation system with a miniaturized laser mounted on a robotic arm. The company was founded by Alfredo E. Bruno, Philippe Cattin, Philipp Jürgens, and Hans-Florian Zeilhofer in 2011 and is headquartered in Allschwil, Switzerland.

Crelux GmbH provides structure based drug discovery solutions. The firm provides customized services to support hit-finding, conformational analysis and lead optimization, including protein production, biophysical assays, fragment screening, and X-ray crystallography. It works for pharma, biotech and research organizations. The company was founded by Ismail Moarefi, Martin Ried and Michael Schaeffer and is headquartered in Martinsried, Germany.

R+V Versicherung AG (Investment Portfolio) (R+V Versicherung IP) is the investment portfolio division of R+V Versicherung AG, itself a subsidiary of DZ Bank AG in Germany. DZ Bank AG forms part of the cooperative financial network comprised of credit unions (Volksbanken and Raiffeisenbanken) for which they serve as the "central bank" and commercial bank. The firm was founded in 1994 when R+V Versicherung Holding merged with Rhen-Main Rückversicherungsgesellschaft AG and is headquartered in Wiesbaden. R+V Versicherung IP provides a range of insurance needs including automobile, liability and accident insurance to private and corporate customers. They offer their services in branches of the Volks- and Raiffeisen banks across Germany, and also sells through local representatives and agencies. They maintain close ties with German SMEs, typically in wholesaling and retailing, the skilled trades, the commercial sector and agriculture.

Leman Micro Devices SA engages in the development of sensor and software systems that measures blood pressure, body temperature, blood oxygen saturation, heart rate and respiration rate in smartphone. The company was founded by Chris Elliott and Mark-Eric Jones in 2010 and is headquartered in Lausanne, Switzerland.

Bio-Bac, Inc. specializes in biological treatment of organic waste through a bacterial bioaugmentation process. Its solutions include wastewater treatment, nitrification – ammonia degradation, ponds and water gardens, golf, hydrocarbons, household and commercial and agricultural treatment. The company is headquartered in Sherbrooke, Canada.

Peripal AG engages in the development and commercialization of aid for the dialysis. It offers PeriSafe a novel patient assist device for the safe and easy connection in Peritoneal Dialysis. The company was founded by Sandra Neumann in 2015 and is headquartered in Zurich, Switzerland.

MTIP AG (MTIP) is an independent private equity/venture capital firm founded in 2014. The firm is headquartered in Basel, Switzerland.

BC Platforms AG provides powerful genomic data management and analysis solutions. It offers pharmaceutical, biobank, healthcare and academia products. The company was founded by Timo Kanninen in 1997 and is headquartered in Basel, Switzerland.

MedNet GmbH provides standard and customized components for medical devices and other industries from a single source. The private company is based in Muenster, Germany. The CEOs are David Thaler, Inge Bröskamp. The German company was founded in 1990.

AOT AG develops and manufactures robotic surgery equipment. Its technologies include laser photoablation, navigation, planning, and image tools, and real time controlling systems. The company was founded in 2011 and is headquartered in Basel, Switzerland.